Thursday Dec 10 | Bioscience Technology
Endologix adds former CoreValve CEO to its board
Endologix Inc., which develops treatments for aortic disorders, said on Thursday that former CoreValve CEO and President Dan Lemaitre will join its board.
Endologix asks court to stay Cook Medical lawsuit
Endologix Inc. said Tuesday it has asked a U.S. District Court to stay a patent lawsuit being brought by Cook Medical.
Endologix Receives IDE Approval For Fully Percutaneous Approach To EVAR
Main Category: Vascular Also Included In: Medical Devices / Diagnostics ; Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials Article Date: 19 Nov 2009 - 2:00 PST Endologix, Inc.
Customer Interaction Solutions
Endologix Down 7.5% Since SmarTrend's Sell Recommendation
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Endologix on October 13, 2009 at $5.13. Since then, Endologix has returned 7.5% as of today's recent price of $4.74. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial.
Customer Interaction Solutions
BUYINS.NET: EXLP, ELGX, MIPS, PEBO, AWBC, HMNF Expected To Be Lower...
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and October earnings reports.
Customer Interaction Solutions
PicksThatMove: www.PicksThatMove.com: 'Picks that move' Alerts,...
August 20, 2009 StealthGas Inc. trading at $4.96 on a volume of 19,819 shares. In a press release out on August 20, 2009 StealthGas Inc.
Also on Topix